|
| eIF4A1 Rabbit mAb |
|
| LTA22172 |
|
| 100ul |
|
|
$501
In stock
|
|
| eIF4A1 Rabbit mAb is produced by immunizing Rabbit with A synthetic peptide corresponding to a sequence within amino acids 1-100 of human eIF4A1 (P60842). |
|
| DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I |
|
| Human |
|
| 1973 |
|
| P60842 |
|
| Synthetic Peptide |
|
| Rabbit |
|
| Monoclonal |
|
| WB,IHC,IF/ICC,IP |
|
| Human,Mouse,Rat |
|
| 46kDa |
|
| WB,1:500 - 1:2000|IHC-P,1:50 - 1:200|IF/ICC,1:50 - 1:200|IP,1:500 - 1:1000 |
|
|
Reconstituted antibodies stable at -80C for 12 months, 4C for 1 week. Avoid repeated freeze-thaw cycles.
|
|
|
Shipped at ambient temperature.
|
|
|
Centrifuge tubes before opening. Dissolve the lyophilized antibodies in distilled water. 5-10% glycerol is recommended.
|
|
|  |
